Revium Rx. RVRC
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2001-08-22
Revium Rx. financials (annual, from 10-K)
| Metric | FY2025 |
|---|---|
| Income tax | $358,000 |
| Net income | -$13.4M |
| EPS (diluted) | $-0.22 |
| Cash & equivalents | $1.7M |
| Total assets | $8.3M |
| Total liabilities | $1.4M |
| Shareholders' equity | $6.9M |
Source: SEC EDGAR filings · CIK 0001839140 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.